Compare Akanda Corp (AKAN) With Other Cannabis Stocks

Head-to-head stock comparisons across price, valuation, financials, and growth metrics

Company

Akanda Corp (AKAN)

Price

$0.82

Change

-2.84%

Market Cap

$1.7M

Sector

International

International Sector Peers

All International cannabis companies sorted by market capitalization. Click any ticker to see a detailed head-to-head comparison.

TickerNamePriceChange %MCap
BBRRFBlueberries Medical Corp$0.01+19.19%$6.0M
IMCCIM Cannabis Corp$0.90-5.26%$5.4M
CSUICannabis Suisse Corp$0.010.00%$848.4K

Top Matchups by Market Cap

Companies closest to Akanda Corp in market capitalization — the most meaningful head-to-head comparisons.

CBDNFCBD

CBD Global Sciences

MCap: $1.8M

$0.04+16.39%
Compare
ELLXFCBD

Elixinol Global

MCap: $1.9M

$0.010.00%
Compare
AYRWFMSO

Ayr Wellness

MCap: $1.9M

$0.02-8.57%
Compare
XXIIBiotech

22nd Century Group

MCap: $2.0M

$3.88+1.97%
Compare
CANBMSO

Canbiola Inc

MCap: $1.4M

$0.020.00%
Compare

Cross-Sector Comparisons

Top cannabis companies outside the International sector. Compare across different business models and market segments.

JAZZBiotech

Jazz Pharmaceuticals

MCap: $10.99B

$178.55-1.66%
Compare
SMGAncillary

Scotts Miracle-Gro

MCap: $3.54B

$60.96+0.96%
Compare
CURLFMSO

Curaleaf Holdings

MCap: $1.80B

$2.36+2.83%
Compare
TPBAncillary

Turning Point Brands

MCap: $1.73B

$90.62+0.69%
Compare
GTBIFMSO

Green Thumb Industries

MCap: $1.54B

$6.56+7.01%
Compare

Comparing AKAN in the Cannabis Market

Akanda Corp (AKAN) is a International-sector cannabis company trading at $0.82 per share with a market capitalization of $1.7M. Among its International peers, AKAN ranks #3 by market cap, with trailing twelve-month revenue of $0 and a gross margin of 0.0%. The stock has moved -2.84% in the current session, trading on the NASDAQ exchange.

When comparing AKAN against other cannabis stocks, investors should consider key financial metrics including price-to-sales ratio (N/A), revenue growth (0.00% YoY), and balance sheet strength (cash of $0 vs. debt of $0). The comparison tables above allow you to evaluate Akanda Corp relative to 3 sector peers and leading companies across all cannabis sub-sectors, helping you identify which stocks offer better value, stronger growth, or more favorable risk profiles.

Frequently Asked Questions

How does AKAN compare to other International stocks?+
Akanda Corp has a market cap of $1.7M, placing it among 4 companies in the International sector. Its price-to-sales ratio is N/A and its gross margin is 0.0%. Use the table above to compare these metrics against every International peer.
What is AKAN's biggest competitor?+
By market capitalization, the closest comparable company is CBD Global Sciences (CBDNF) with a market cap of $1.8M. Click the compare link to view a full head-to-head analysis.
Is AKAN overvalued compared to its peers?+
Akanda Corp trades at a P/S ratio of N/A. Compare this to sector peers in the table above to determine relative valuation. A lower P/S may indicate relative value, while a higher P/S may reflect growth expectations.
Which cannabis stock has better margins than AKAN?+
Akanda Corp has a gross margin of 0.0%. Among its International peers, 0 companies report higher gross margins. See the Sector Peers table for a full ranking.
Can I compare AKAN to stocks in other cannabis sectors?+
Yes. The Cross-Sector Comparisons section above features top companies from sectors outside International. You can click any company to see a full side-by-side comparison with AKAN covering price, valuation, financials, and growth metrics.

Related Pages

Disclaimer: The comparison data on this page is for informational purposes only and does not constitute financial advice, investment recommendations, or an endorsement of any security. Cannabis stocks are highly volatile and subject to unique regulatory risks. Always conduct your own research and consult a licensed financial advisor before making investment decisions.Cannabismarketcap does not guarantee the accuracy or completeness of any data presented.